Effects of chronic jet lag on tumor progression in mice

Cancer Research

Volumn 64, Issue 21, 2004, Pages 7879-7885

  Filipski, Elisabeth ^a   Delaunay, Franck ^b   King, Verdun M ^c   Wu, Ming Wei ^a   Claustrat, Bruno ^d   Gréchez Cassiau, Aline ^b   Guettier, Catherine ^a   Hastings, Michael H ^e   Francis, Lévi ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d HÔPITAL NEUROLOGIQUE   (France)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; PER1 PROTEIN; REV PROTEIN; TRANSCRIPTION FACTOR CLOCK;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GENE EXPRESSION REGULATION; JET LAG; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; TUMOR GROWTH;

ANIMALS; CHRONIC DISEASE; CIRCADIAN RHYTHM; DISEASE PROGRESSION; GENE EXPRESSION; JET LAG SYNDROME; MALE; MICE; NEOPLASMS; SUPRACHIASMATIC NUCLEUS;

EID: 7444245092     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0674     Document Type: Article

References (41)

1. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000;6:3038-45.
2. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst (Bethesda) 2000;92:994-1000.
3. Mormont MC, Lévi F. Cancer chronotherapy: principles, applications and perspectives. Cancer (Phila) 2003;97:155-69.
4. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature (Lond) 2002;418:935-41.
5. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell 2002;111:919-22.
6. Leloup JC, Goldbeter A. Toward a detailed computational model for the mammalian circadian clock. Proc Natl Acad Sci USA 2003;100:7051-6.
7. Delaunay F, Laudet V. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet 2002;18:595-7.
8. Klein DC, Moore RY, Reppert SM, editors. The suprachiasmatic nucleus: the mind's clock. New York: Oxford University Press; 1991.
9. Filipski E, King VM, Li XM, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst (Bethesda) 2002;94:690-7.
10. Fu L, Pelicano H, Liu J, Huang P, Lee CC. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
11. Zheng B, Larkin DW, Albrecht U. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature (Lond) 1999;400:169-73.
12. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst (Bethesda) 2001;93:1563-8.
13. Schernhammer ES, Laden F, Speizer FE et al. Night-shift work and risk of colorectal cancer in the Nurses' Health Study. J Natl Cancer Inst (Bethesda) 2003;95:825-8.
14. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst (Bethesda) 2001;93:1557-62.
15. Rafnsson V, Tulinius H, Jonasson J, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001;12:95-101.
16. Pukkala E, Aspholm R, Auvinen A, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. Br Med J 2002;325:567-71.
17. Reynolds P, Cone J, Layefsky M, Goldberg D, Hurley S. Cancer incidence in California flight attendants (United States). Cancer Causes Control 2002;13:317-24.
18. Hansen J. Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst (Bethesda) 2001;93:1513-5.
19. Pévet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res 2002;309:183-91.
20. 1 mice. Am J Physiol [Regulatory Integrative Comp Physiol] 2000;278:R924-30.
21. Hastings MH, Field MD, Maywood ES, Weaver DR, Reppert SM. Differential regulation of mPER1 and mTIM proteins in the mouse suprachiasmatic nuclei: new insights into a core clock mechanism. J Neurosci 1999;19:RC11.
22. Li XM, Beau J, Delagrange P, Mocaër E, Lévi F. Circadian rhythm entrainment with melatonin, melatonin receptor antagonist S22153 or their combination in mice exposed to constant light. J Pineal Res 2004;37:176-84.
23. Marques MD, Waterhouse JM. Masking and the evolution of circadian rhythmicity. Chronobiol Int 1994;11:146-55.
24. Reddy AB, Field MD, Maywood ES, Hastings MH. Differential resynchronisation of circadian clock gene expression within the suprachiasmatic nuclei of mice subjected to experimental jet lag. J Neurosci 2002;22:7326-30.
25. Grundschober C, Delaunay F, Puhlhofer A, et al. Circadian regulation of diverse gene products revealed by mRNA expression profiling of synchronized fibroblasts. J Biol Chem 2001;276:46751-8.
26. Modjtahedi N, Haddada H, Lamonerie T, et al. TGF-alpha production correlates with tumorigenicity in clones of the SW613-S human colon carcinoma cell line. Int J Cancer 1992;52:483-90.
27. De Prins J, Hequet B. Data processing in chronobiological studies. In: Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer Verlag; 1992. p. 90-112.
28. Haus E, Lakatua D, Halberg F. The internal timing of several circadian rhythms in the blinded mouse. Exp Med Surg 1967;25:7-45.
29. Nagano M, Adachi A, Nakahama K et al. An abrupt shift in the day/night cycle causes desynchrony in the mammalian circadian center. J Neurosci 2003;23:6141-51.
30. Tei H, Okamura H, Shigeyoshi Y, et al. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature (Lond)1997;389:512-6.
31. Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERB alpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-60.
32. Balsalobre A, Brown SA, Marcacci L, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science (Wash DC) 2000;289:2344-7.
33. Granda T, Lévi F. Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int 2002;19:21-41.
34. Matsuo T, Yamaguchi S, Mitsui S, et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science (Wash DC) 2003;302:255-9.
35. Koyanagi S, Kuramoto Y, Nakagawa H, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003;63:7277-83.
36. Drasdo D, Hohme S. Individual-based approaches to birth and death in avascular tumors. Mathematical Computer Modelling 2003;37:1163-75.
37. Chaplain MAJ. Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development. Mathematical Computer Modelling 1996;23:47-87.
38. Wu MW, Li XM, Xian LJ, Lévi F. Effects of meal timing on tumor progression in mice. Life Sciences 2004;75:1181-93.
39. Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med 2001;7:356-60.
40. Li XM, Vincenti M, Lévi F. Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice. Chronobiol Int 2002;19:43-55.
41. Lévi F, Zidani R, Misset JL for the International Organization for Cancer Chronotherapy. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997;350:681-6.